AAAAAA

   
Results: 1-14 |
Results: 14
BIOLOGICAL CONSEQUENCES OF OXIDATION IN ATHEROSCLEROSIS AND OTHER PATHOLOGIES - LIPOPROTEIN OXIDATION IN BRAIN ARTERIES
Authors: PALINSKI W HORKKO S
Citation: W. Palinski et S. Horkko, BIOLOGICAL CONSEQUENCES OF OXIDATION IN ATHEROSCLEROSIS AND OTHER PATHOLOGIES - LIPOPROTEIN OXIDATION IN BRAIN ARTERIES, NMCD. Nutrition Metabolism and Cardiovascular Diseases, 7(3), 1997, pp. 237-247
THE EPITOPES FOR SOME ANTIPHOSPHOLIPID ANTIBODIES ARE ADDUCTS OF OXIDIZED PHOSPHOLIPID AND BETA(2) GLYCOPROTEIN-1 (AND OTHER PROTEINS)
Authors: HORKKO S MILLER E BRANCH DW PALINSKI W WITZTUM JL
Citation: S. Horkko et al., THE EPITOPES FOR SOME ANTIPHOSPHOLIPID ANTIBODIES ARE ADDUCTS OF OXIDIZED PHOSPHOLIPID AND BETA(2) GLYCOPROTEIN-1 (AND OTHER PROTEINS), Proceedings of the National Academy of Sciences of the United Statesof America, 94(19), 1997, pp. 10356-10361
STRUCTURAL IDENTIFICATION BY MASS-SPECTROMETRY OF OXIDIZED PHOSPHOLIPIDS IN MINIMALLY OXIDIZED LOW-DENSITY-LIPOPROTEIN THAT INDUCE MONOCYTEENDOTHELIAL INTERACTIONS AND EVIDENCE FOR THEIR PRESENCE IN-VIVO/
Authors: WATSON AD LEITINGER N NAVAB M FAULL KF HORKKO S WITZTUM JL PALINSKI W SCHWENKE D SALOMON RG SHA W SUBBANAGOUNDER G FOGELMAN AM BERLINER JA
Citation: Ad. Watson et al., STRUCTURAL IDENTIFICATION BY MASS-SPECTROMETRY OF OXIDIZED PHOSPHOLIPIDS IN MINIMALLY OXIDIZED LOW-DENSITY-LIPOPROTEIN THAT INDUCE MONOCYTEENDOTHELIAL INTERACTIONS AND EVIDENCE FOR THEIR PRESENCE IN-VIVO/, The Journal of biological chemistry, 272(21), 1997, pp. 13597-13607
CLONING OF MONOCLONAL AUTOANTIBODIES TO EPITOPES OF OXIDIZED LIPOPROTEINS FROM APOLIPOPROTEIN E-DEFICIENT MICE - DEMONSTRATION OF EPITOPES OF OXIDIZED LOW-DENSITY-LIPOPROTEIN IN HUMAN PLASMA
Authors: PALINSKI W HORKKO S MILLER E STEINBRECHER UP POWELL HC CURTISS LK WITZTUM JL
Citation: W. Palinski et al., CLONING OF MONOCLONAL AUTOANTIBODIES TO EPITOPES OF OXIDIZED LIPOPROTEINS FROM APOLIPOPROTEIN E-DEFICIENT MICE - DEMONSTRATION OF EPITOPES OF OXIDIZED LOW-DENSITY-LIPOPROTEIN IN HUMAN PLASMA, The Journal of clinical investigation, 98(3), 1996, pp. 800-814
ANTIPHOSPHOLIPID ANTIBODIES ARE DIRECTED AGAINST EPITOPES OF OXIDIZEDPHOSPHOLIPIDS - RECOGNITION OF CARDIOLIPIN BY MONOCLONAL-ANTIBODIES TO EPITOPES OF OXIDIZED LOW-DENSITY-LIPOPROTEIN
Authors: HORKKO S MILLER E DUDL E REAVEN P CURTISS LK ZVAIFLER NJ TERKELTAUB R PIERANGELI SS BRANCH DW PALINSKI W WITZTUM JL
Citation: S. Horkko et al., ANTIPHOSPHOLIPID ANTIBODIES ARE DIRECTED AGAINST EPITOPES OF OXIDIZEDPHOSPHOLIPIDS - RECOGNITION OF CARDIOLIPIN BY MONOCLONAL-ANTIBODIES TO EPITOPES OF OXIDIZED LOW-DENSITY-LIPOPROTEIN, The Journal of clinical investigation, 98(3), 1996, pp. 815-825
ANTIPHOSPHOLIPID ANTIBODIES ARE DIRECTED AGAINST EPITOPES OF OXIDIZEDPHOSPHOLIPIDS
Authors: HORKKO S MILLER E DUDL EP REAVEN PD CURTISS LK BRANCH W PALINSKI W WITZTUM JL
Citation: S. Horkko et al., ANTIPHOSPHOLIPID ANTIBODIES ARE DIRECTED AGAINST EPITOPES OF OXIDIZEDPHOSPHOLIPIDS, Circulation, 94(8), 1996, pp. 6-6
FIBROBLASTS EXPRESSING 15-LIPOXYGENASE GENERATE A BIOACTIVE, MINIMALLY MODIFIED LOW-DENSITY-LIPOPROTEIN
Authors: SIGARI F BARNETT J HORKKO S WITZTUM JL REAVEN PD
Citation: F. Sigari et al., FIBROBLASTS EXPRESSING 15-LIPOXYGENASE GENERATE A BIOACTIVE, MINIMALLY MODIFIED LOW-DENSITY-LIPOPROTEIN, Circulation, 94(8), 1996, pp. 2326-2326
STRUCTURAL IDENTIFICATION OF OXIDIZED PHOSPHOLIPIDS THAT INDUCE MONOCYTE ENDOTHELIAL INTERACTIONS BY ELECTROSPRAY MASS-SPECTROMETRY/
Authors: WATSON AD LEITINGER N HORKKO S WITZTUM JL PALINSKI W FAULL KF SALOMON RG SHA W FOGELMAN AM BERLINER JA
Citation: Ad. Watson et al., STRUCTURAL IDENTIFICATION OF OXIDIZED PHOSPHOLIPIDS THAT INDUCE MONOCYTE ENDOTHELIAL INTERACTIONS BY ELECTROSPRAY MASS-SPECTROMETRY/, Circulation, 94(8), 1996, pp. 2327-2327
MODIFICATION OF VLDL APOPROTEIN-B BY ACETALDEHYDE ALTERS APOPROTEIN BMETABOLISM
Authors: KERVINEN K HORKKO S BELTZ WF KESANIEMI YA
Citation: K. Kervinen et al., MODIFICATION OF VLDL APOPROTEIN-B BY ACETALDEHYDE ALTERS APOPROTEIN BMETABOLISM, Alcohol, 12(3), 1995, pp. 189-194
DECREASED CLEARANCE OF LOW-DENSITY-LIPOPROTEIN IN UREMIC PATIENTS UNDER DIALYSIS TREATMENT
Authors: HORKKO S HUTTUNEN K KESANIEMI YA
Citation: S. Horkko et al., DECREASED CLEARANCE OF LOW-DENSITY-LIPOPROTEIN IN UREMIC PATIENTS UNDER DIALYSIS TREATMENT, Kidney international, 47(6), 1995, pp. 1732-1740
EFFECTS OF 3 TREATMENT MODES ON PLASMA-LIPIDS AND LIPOPROTEINS IN UREMIC PATIENTS
Authors: HORKKO S HUTTUNEN K LAARA E KERVINEN K KESANIEMI YA
Citation: S. Horkko et al., EFFECTS OF 3 TREATMENT MODES ON PLASMA-LIPIDS AND LIPOPROTEINS IN UREMIC PATIENTS, Annals of medicine, 26(4), 1994, pp. 271-282
DECREASED CLEARANCE OF LOW-DENSITY-LIPOPROTEIN IN PATIENTS WITH CHRONIC-RENAL-FAILURE
Authors: HORKKO S HUTTUNEN K KORHONEN T KESANIEMI YA
Citation: S. Horkko et al., DECREASED CLEARANCE OF LOW-DENSITY-LIPOPROTEIN IN PATIENTS WITH CHRONIC-RENAL-FAILURE, Kidney international, 45(2), 1994, pp. 561-570
H-1 NMR-BASED ABSOLUTE QUANTITATION OF HUMAN LIPOPROTEINS AND THEIR LIPID CONTENTS DIRECTLY FROM PLASMA
Authors: ALAKORPELA M KORHONEN A KEISALA J HORKKO S KORPI P INGMAN LP JOKISAARI J SAVOLAINEN MJ KESANIEMI YA
Citation: M. Alakorpela et al., H-1 NMR-BASED ABSOLUTE QUANTITATION OF HUMAN LIPOPROTEINS AND THEIR LIPID CONTENTS DIRECTLY FROM PLASMA, Journal of lipid research, 35(12), 1994, pp. 2292-2304
DECREASED CLEARANCE OF UREMIC AND MILDLY CARBAMYLATED LOW-DENSITY-LIPOPROTEIN
Authors: HORKKO S HUTTUNEN K KERVINEN K KESANIEMI YA
Citation: S. Horkko et al., DECREASED CLEARANCE OF UREMIC AND MILDLY CARBAMYLATED LOW-DENSITY-LIPOPROTEIN, European journal of clinical investigation, 24(2), 1994, pp. 105-113
Risultati: 1-14 |